id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
224461,84a1271d-86ed-4915-8269-802517adc9a1,YY,"TWENTY-FIRST CENTURY GROUP, INC.",38687,SCHERING-PLOUGH,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2003-04-01T00:00:00-05:00
224524,9d80bd91-008d-4c78-bc98-06663a19c87d,YY,"CEPHALON, INC.",8761,CEPHALON INC,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",,100000,0,0,2003-04-01T00:00:00-05:00
244086,9c997a74-1b43-4ef0-8d2f-a4ea2b9ba20f,YY,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2003,year_end,PHA,,"Agriculture, Dept of (USDA),Bureau of Citizenship & Immigration Services (BCIS),Centers For Disease Control & Prevention (CDC),Education, Dept of,Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,Social Security Administration (SSA),State, Dept of (DOS)",,80000,0,0,2003-08-18T00:00:00-04:00
253732,a72a19d5-6f7f-40aa-829c-7ff222eb44dc,YY,D. LYNN JOHNSON,86653,KING PHARMACEUTICALS INC,2003,year_end,PHA,Asked a Senate office to contact the FDA to determine why the agency would not agree to King Pharmaceuticals' promoting the use of AtroPen (approved by the FDA) with physicians and the public by using FDA approved informational materials.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2004-01-06T00:00:00-05:00
253736,70fd7cd6-5489-44ab-90e1-bd6e5d9771e1,YY,D. LYNN JOHNSON,86653,KING PHARMACEUTICALS INC,2003,year_end,PHA,Asked a Senate office to contact the FDA to determine why the agency would not agree to King Pharmaceuticals' promoting the use of AtroPen (approved by the FDA) with physicians and the public by using FDA approved informational materials.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2004-01-06T00:00:00-05:00
253998,6e0f89b7-a40f-4e46-991e-6cb43a448702,YY,"EMD SERONO, INC.",48736,EMD SERONO INC,2003,year_end,PHA,"Amendments to Hatch-Waxman exclusivity policies
Food & Drug Administration appropriations
Reimportation of prescription drugs from foreign sources","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE",,35000,0,0,2004-01-12T00:00:00-05:00
254452,edfcfa59-3d39-4df3-b113-224f61059d3d,YTY,"ALBERTINE ENTERPRISES, INC.",795,NATL ASSN OF RV PARKS & CAMPGROUNDS,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",0,,0,0,2004-01-20T00:00:00-05:00
254802,8143b957-4cea-453e-a5f5-6dff5dad4fd8,YY,MARSHALL BRACHMAN,6848,PHARMAFAB,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2004-01-26T00:00:00-05:00
255052,151edbbf-4af1-4ef4-bfd7-24b7f1dbcbed,YY,"MAYBERRY & ASSOCIATES, LLC",51968,PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION,2003,year_end,PHA,,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",0,,0,0,2004-01-29T00:00:00-05:00
255187,3c4a6a2a-2c69-4a95-acf0-8ef0e7d381f6,YY,"MAYBERRY & ASSOCIATES, LLC",51968,HEALTHCARE COMPLIANCE PACKAGING COUNCIL,2003,year_end,PHA,,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",0,,0,0,2004-01-29T00:00:00-05:00
255454,155b04d9-fcdc-4dbc-a1f6-b0353639559a,YY,RETIRESAFE,11025,RETIRESAFE,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",,260000,0,0,2004-01-30T00:00:00-05:00
255536,e2efe211-6af5-41be-92db-68cd26203856,YY,UNIVERSITY OF ILLINOIS,39427,UNIVERSITY OF ILLINOIS,2003,year_end,PHA,,"Agriculture, Dept of (USDA),Bureau of Citizenship & Immigration Services (BCIS),Commerce, Dept of (DOC),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Federal Aviation Administration (FAA),Federal Highway Administration (FHA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Indian Health Service,Justice, Dept of (DOJ),Natl Aeronautics & Space Administration (NASA),Natl Endowment for the Arts,Natl Foundation on the Arts & Humanities,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,Technology Administration,Transportation, Dept of (DOT),U.S. Agency for International Development (USAID),U.S. International Development Cooperation Agency,Veterans Affairs, Dept of (VA)",,40000,0,0,2004-01-30T00:00:00-05:00
255735,e3173aab-3710-4168-b90c-56524cd6fcf5,YY,ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM,58534,ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM,2003,year_end,PHA,,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,180000,0,0,2004-02-02T00:00:00-05:00
255861,bb525b07-e864-475c-b8ba-e3c16fc36021,YY,MR. MARK SHARPE,83455,ANAZAOHEALTH CORPORATION,2003,year_end,PHA,,"Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2004-02-02T00:00:00-05:00
256196,c1b3e91e-ae45-4fb1-9155-06acbc09e51b,YY,"TCH GROUP, LLC",51478,SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ),2003,year_end,PHA,"1. S.1, H.R. 1, Medicare prescription drug and modernization act of 2003.
2. S. 1113, Improved access to osteoporosis testing act of 2003.
3. S. 465, A bill to amend title XVIII of the social security act to expand Medicare coverage of certain self-injected biologicals.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2004-02-05T00:00:00-05:00
256248,cf7c166b-bf45-438e-9841-efbb2d22a7ef,YY,REGENCE BLUECROSS BLUESHIELD OF UTAH,87791,REGENCE BLUECROSS BLUESHIELD OF UTAH,2003,year_end,PHA,"H.R. 1, Medicare Prescription Drug and Modernization Act of 2003, Title I – Medicare Prescription Drug Benefit, Title XI – Access to Affordable Pharmaceuticals Act.

S. 1, Prescription Drug and Medicare Improvement Act of 2003, Title I – Medicare Prescription Drug Benefit, Section 101 – Medicare Voluntary Prescription Drug Delivery Program, Section 103 – Medigap, Section 111 – Medicare Prescription Drug Discount Card and Transitional Assistance for Low-Income Beneficiaries.","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2004-02-05T00:00:00-05:00
256268,3b71b0a3-d411-41a2-88b7-f5b9d9f6516f,YY,"TCH GROUP, LLC",51478,PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA,2003,year_end,PHA,"1. S.1, H.R. 1 Medicare prescription drug and modernization act of 2003
2. S. 650 Pediatric research equity act of 2003
3. H.R. 2427, Pharmaceutical market access act of 2003","HOUSE OF REPRESENTATIVES,SENATE",120000,,0,0,2004-02-05T00:00:00-05:00
256331,4cdf0bfd-1b1a-4f18-b4ca-640be7cef894,YY,BROYDRICK & ASSOCIATES,7268,BARR LABORATORIES,2003,year_end,PHA,generic drug legislation,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2004-02-06T00:00:00-05:00
256367,07881907-59bf-47b5-9c65-bfff50326fbb,YY,"TCH GROUP, LLC",51478,BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO),2003,year_end,PHA,"S. 1, H.R. 1, Medicare and Prescription Drug and Modernization Act of 2003.",SENATE,40000,,0,0,2004-02-06T00:00:00-05:00
256836,a2827e4b-2b53-463c-923a-36b8c6d30245,YY,"TIMMONS AND COMPANY, INC.",38164,BRISTOL-MYERS SQUIBB CO,2003,year_end,PHA,,"Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",170000,,0,0,2004-02-10T00:00:00-05:00
256983,066dbd27-d8b4-4b70-9536-57ceac81b438,YY,WINNING STRATEGIES WASHINGTON,50796,CVS HEALTH CONNECTION,2003,year_end,PHA,Promoting CVS Health Connection initiative to assess the rise of type-2 diabetes in children,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2004-02-10T00:00:00-05:00
257032,066638b5-dc3d-4a68-a4c3-84ba40858720,YY,MICHAEL POLLARD,87836,MEDCO HEALTH SOLUTIONS INC,2003,year_end,PHA,"S. 1 “Prescription Drug and Medicare Improvement Act of 2003,” all provisions relating to the prescriptions drug benefit.

H.R. 1 “Medicare Prescription Drug and Modernization Act of 2003,” all provisions relating to the prescription drug benefit.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",100000,,0,0,2004-02-10T00:00:00-05:00
257056,c81961bd-e1c5-4eca-bcc9-8a2ec7e23270,YY,NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS,26706,NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS,2003,year_end,PHA,"Drug Discount Program (Section 340B of the Public Health Service Act); Medicare Reform and Prescription Drug Coverage - H.R.1, S.1.","Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,260000,0,0,2004-02-10T00:00:00-05:00
257238,c1fcd387-e7bc-42a4-80bf-fa1680cb744c,YY,AMERICA'S ESSENTIAL HOSPITALS,27057,AMERICA'S ESSENTIAL HOSPITALS,2003,year_end,PHA,"Section 340B of the Public Health Service Act
S. 1 and H.R. 1
Changing government policy on Medicaid best price exemptions
Compliance guidance on patient assistance programs
Assistance on 340B refunds","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE,Veterans Affairs, Dept of (VA),White House Office",,200000,0,0,2004-02-10T00:00:00-05:00
257909,728d4b94-93f2-43a7-be09-22bf780d4a16,YY,WINNING STRATEGIES WASHINGTON,50796,PFIZER INC,2003,year_end,PHA,Promoting Pfizer Health Solutions initiative to assess the ries of type-2 diabetes in children,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2004-02-11T00:00:00-05:00
258078,61947d76-7a08-4816-ad23-71e97bc2485a,YY,3M COMPANY,25465,3M COMPANY,2003,year_end,PHA,,"Environmental Protection Agency (EPA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT),Treasury, Dept of,U.S. Architectural & Transportation Barriers Compliance Board (ACCESS),U.S. Trade Representative (USTR),Veterans Affairs, Dept of (VA)",,992000,0,0,2004-02-11T00:00:00-05:00
258327,800948f7-da68-40f2-ab4a-2dc42c658acf,YY,FLEISCHMAN AND HARDING LLP,14792,NATL ASSN OF CHAIN DRUG STORES,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2004-02-12T00:00:00-05:00
259006,555edf98-cf4e-46f5-a89b-4062b8ca1574,YY,LENT SCRIVNER & ROTH LLC,22611,PFIZER,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2004-02-12T00:00:00-05:00
259098,f0c07fc8-7bca-478b-800c-08fed59855c1,YY,BIOTECHNOLOGY INNOVATION ORGANIZATION,6245,BIOTECHNOLOGY INNOVATION ORGANIZATION,2003,year_end,PHA,,"Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),Office of the Vice President of the United States,Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),State, Dept of (DOS),Treasury, Dept of,U.S. Trade Representative (USTR),Vice President of the U.S.,White House Office",,2220000,0,0,2004-02-12T00:00:00-05:00
259177,254f52a3-1305-4f6d-90e7-c4f0297e8544,YY,"STUNTZ DAVIS & STAFFIER, P.C.",37141,PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA,2003,year_end,PHA,,HOUSE OF REPRESENTATIVES,20000,,0,0,2004-02-13T00:00:00-05:00
259237,9061ed61-b800-4cfb-b479-f7c6f91454cb,YY,"OLSSON, FRANK, WEEDA, TERMAN & MATZ, PC",30212,ADHERIS,2003,year_end,PHA,,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2004-02-13T00:00:00-05:00
259296,5482b085-f5ae-49b8-9733-3a264523356a,YY,NATIONAL ALLIANCE ON MENTAL ILLNESS,26502,NATIONAL ALLIANCE ON MENTAL ILLNESS,2003,year_end,PHA,,"Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Justice, Dept of (DOJ),SENATE,Veterans Affairs, Dept of (VA)",,40000,0,0,2004-02-13T00:00:00-05:00
260205,f0ac2b19-944a-44a6-b8e9-ef7dba206676,YY,"CONSUMER REPORTS, INC. (F.K.A. CONSUMERS UNION OF UNITED STATES, INC.)",10651,"CONSUMER REPORTS, INC. (F.K.A. CONSUMERS UNION OF UNITED STATES, INC.)",2003,year_end,PHA,"HR 2427 - Pharmaceurical Market Access Act of 2003
Reimportation","Agriculture, Dept of (USDA),Federal Communications Commission (FCC),Federal Reserve System,Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS)",,193121,0,0,2004-02-13T00:00:00-05:00
260562,4f60e2c4-44d2-4f26-8086-ffbe2df653e7,YY,"OLSSON, FRANK, WEEDA, TERMAN & MATZ, PC",30212,SANDOZ,2003,year_end,PHA,,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2004-02-13T00:00:00-05:00
260691,37d6799d-0854-43ad-b51a-11c3a79f1ed9,YY,DLA PIPER LLP (US),76855,BIOVAIL CORP INTL,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2004-02-13T00:00:00-05:00
260737,25405517-55e2-4865-8211-12961673c51e,YY,MAGAZINE PUBLISHERS OF AMERICA,23496,MAGAZINE PUBLISHERS OF AMERICA,2003,year_end,PHA,,"Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of,U.S. Copyright Office,U.S. Postal Service (USPS)",,440000,0,0,2004-02-13T00:00:00-05:00
261203,792af186-1b73-4884-970a-5533d0d6606a,YY,"VAN NESS FELDMAN, LLP",39815,MCKESSON CORPORATION,2003,year_end,PHA,,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2004-02-13T00:00:00-05:00
261204,1ed4468a-915c-45dd-9c1a-564e581a508b,YY,"R. B. MURPHY & ASSOCIATES, LLC",48931,PHRMA,2003,year_end,PHA,,SENATE,20000,,0,0,2004-02-13T00:00:00-05:00
261647,a677a129-e39f-4f40-8f46-8e5b03b55f76,YY,DLA PIPER LLP (US),76855,"HUMAN GENOME SCIENCES, INC.",2003,year_end,PHA,,"Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE",100000,,0,0,2004-02-13T00:00:00-05:00
261826,777784a3-ca04-4f05-8382-e3d69a7f9c0c,YY,"JOLLY/RISSLER, INC.",20835,WASHINGTON COUNCIL ERNST & YOUNG,2003,year_end,PHA,,"Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of",80000,,0,0,2004-02-13T00:00:00-05:00
261980,cc7b60e0-d9e4-4962-9595-0eeb61166e4c,YY,"OLSSON, FRANK, WEEDA, TERMAN & MATZ, PC",30212,BRANDED PHARMACEUTICAL ASSN,2003,year_end,PHA,,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2004-02-13T00:00:00-05:00
262497,a9ac9c12-244e-4e94-b1eb-c30d739c9604,YY,BROYDRICK & ASSOCIATES,7268,SIGMA TAU PHARMACEUTICALS,2003,year_end,PHA,"Orphan Drug Act
reimbursement issues","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2004-02-16T00:00:00-05:00
262584,64c32988-89b4-4e1e-a854-c1cd173384bc,YY,"WILLIAMS AND JENSEN, PLLC",41454,WYETH (FORMERLY AMERICAN HOME PRODUCTS),2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",260000,,0,0,2004-02-17T00:00:00-05:00
263141,1ea03d16-6953-4f4c-84a2-970e21f109b8,YY,WINSTON & STRAWN LLP,41682,BARR LABORATORIES INC,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2004-02-17T00:00:00-05:00
263200,e3de6147-49d5-46ec-9b86-abe5f0e94fdd,YY,RICHARD F. HOHLT,18433,BRISTOL-MYERS SQUIBB COMPANY,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",35000,,0,0,2004-02-17T00:00:00-05:00
263711,ced3fe4e-009f-466a-ab92-e6f88275ed99,YA,REGENCE BLUECROSS BLUESHIELD OF UTAH,87791,REGENCE BLUECROSS BLUESHIELD OF UTAH,2003,year_end,PHA,"H.R. 1, Medicare Prescription Drug and Modernization Act of 2003, Title I – Medicare Prescription Drug Benefit, Title XI – Access to Affordable Pharmaceuticals Act.

S. 1, Prescription Drug and Medicare Improvement Act of 2003, Title I – Medicare Prescription Drug Benefit, Section 101 – Medicare Voluntary Prescription Drug Delivery Program, Section 103 – Medigap, Section 111 – Medicare Prescription Drug Discount Card and Transitional Assistance for Low-Income Beneficiaries.","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2004-02-17T00:00:00-05:00
263945,cd6e0a39-dee8-4fa4-b18a-7656edc1ec85,YY,BLUE CROSS AND BLUE SHIELD ASSOCIATION,6358,BLUE CROSS AND BLUE SHIELD ASSOCIATION,2003,year_end,PHA,"Sections of H1 and S1 pertaining to Prescription Drug Issues; Generic Drugs; Drug Comparative Effectiveness; House Amendment 215 to HR2660 ""Labor HHS Appropriations for FY 2004"".","Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Personnel Management (OPM),SENATE,White House Office",,3940000,0,0,2004-02-17T00:00:00-05:00
264072,7f86059e-e03e-45d0-afe7-f44a8d20c495,YY,"TEVA PHARMACEUTICALS USA, INC.",76695,TEVA PHARMACEUTICALS USA INC,2003,year_end,PHA,,"Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,640000,0,0,2004-02-17T00:00:00-05:00
264241,9d0c8080-5340-42c5-a75b-563cd9691d30,YY,WILMER CUTLER PICKERING HALE AND DORR LLP,41534,WYETH,2003,year_end,PHA,,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2004-02-17T00:00:00-05:00
264286,6d86a55d-de93-4a7c-abd7-7b4da713c9bb,YT,HIATT COMMUNICATIONS,58294,POLICY IMPACT STRATEGIC COMMUNICATIONS,2003,year_end,PHA,,"Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE,U.S. Agency for International Development (USAID)",12500,,0,0,2004-02-17T00:00:00-05:00
264293,be328661-8525-4e5d-8f03-6fbe23b1b3f3,YY,THE COHEN GROUP,70370,DLA PIPER US LLP,2003,year_end,PHA,,"Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),State, Dept of (DOS),U.S. Agency for International Development (USAID)",150000,,0,0,2004-02-17T00:00:00-05:00
264429,13f0b490-85a6-427f-a4b6-ba1b03179d76,YT,PENNSYLVANIA AVE ASSOCIATES,84296,SRI INTL,2003,year_end,PHA,,"Defense, Dept of (DOD),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of",0,,0,0,2004-02-17T00:00:00-05:00
264457,8f490ba7-4517-4e6d-9b6a-9097097b0e36,YAY,WINSTEAD CONSULTING GROUP,80097,RX&D,2003,year_end,PHA,,"Health & Human Services, Dept of (HHS)",70000,,0,0,2004-02-17T00:00:00-05:00
264653,3c250a50-1846-49cf-99ca-6637e5beb436,YY,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,27478,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",,20000,0,0,2004-02-17T00:00:00-05:00
265237,c7ba20b9-2df2-41a1-8e16-7b2719a2ae3d,YY,AARP,1694,AARP,2003,year_end,PHA,,"Administration on Aging,Equal Employment Opportunity Commission (EEOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Office of Management & Budget (OMB),Office of the Comptroller of the Currency (OCC),Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office",,16380000,0,0,2004-02-17T00:00:00-05:00
265705,bc3726f8-40bf-48b5-b379-c8105148badf,YY,SQUIRE PATTON BOGGS,30906,PFIZER INC,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2004-02-17T00:00:00-05:00
265842,f2e38460-1171-4b48-b483-cdc3e5be6bd4,YY,SRI INTERNATIONAL,90990,SRI INTERNATIONAL,2003,year_end,PHA,,"Defense, Dept of (DOD),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of",,100000,0,0,2004-02-17T00:00:00-05:00
265949,b53bdf1b-7a00-489d-8c43-d22c400d80bf,YYY,WINSTEAD CONSULTING GROUP,80097,RX&D,2003,year_end,PHA,,"Health & Human Services, Dept of (HHS)",70000,,0,0,2004-02-17T00:00:00-05:00
266503,19b8c896-e241-4817-a7de-f4f1b2db429c,YY,"PODESTA GROUP, INC.",31680,PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA,2003,year_end,PHA,,"Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE",180000,,0,0,2004-02-17T00:00:00-05:00
267164,fb77fcf0-0e85-4d05-aa3c-1c53eb14eb99,YY,SQUIRE PATTON BOGGS,30906,HOFFMANN-LA ROCHE INC,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",360000,,0,0,2004-02-17T00:00:00-05:00
267540,3c34f5fb-fef5-4a96-9c5e-37527364fa15,YY,THE HARBOUR GROUP,66636,PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA (PHRMA),2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",140000,,0,0,2004-02-17T00:00:00-05:00
267615,444aa7d4-44d0-4c89-8915-3aba947390a6,YY,"MEDCO HEALTH SOLUTIONS, INC",89177,MEDCO HEALTH SOLUTIONS INC,2003,year_end,PHA,,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,500000,0,0,2004-02-17T00:00:00-05:00
267802,c682c080-3b45-4f66-97fe-47c8d168db5d,YY,BERGNER BOCKORNY CASTAGNETTI HAWKINS & BRAIN,6006,GLAXO SMITH KLINE,2003,year_end,PHA,,"Executive Office of the President (EOP),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)",100000,,0,0,2004-02-17T00:00:00-05:00
267836,8759d69f-b3ff-41c8-a840-4a1c9fb12e4f,YY,"THE OB-C GROUP, LLC",29802,HEALTHCARE DISTRIBUTION MANAGEMENT ASSN,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2004-02-17T00:00:00-05:00
268072,31feb5f3-f23f-41b6-92ab-5661bdc38709,YYY,"ASSOCIATION OF NATIONAL ADVERTISERS, INC.",4653,"ASSOCIATION OF NATIONAL ADVERTISERS, INC.",2003,year_end,PHA,,"Federal Communications Commission (FCC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE",,420000,0,0,2004-02-17T00:00:00-05:00
268755,b2317ae2-0b1d-43e7-8758-819a4b34d6c3,YY,CARMEN GROUP INCORPORATED,8316,WALGREEN COMPANY,2003,year_end,PHA,,"Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT),White House Office",180000,,0,0,2004-02-17T00:00:00-05:00
268799,acd4286f-1c53-4111-9eaf-858f18edd390,YY,WINSTEAD PC,42741,AVENTIS PHARMACEUTICALS,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",0,,0,0,2004-02-17T00:00:00-05:00
268828,7ebd0382-fccb-4908-8213-874fe2adfe35,YY,MICHAEL POLLARD,87836,MEDCO HEALTH SOLUTIONS INC,2003,year_end,PHA,,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",100000,,0,0,2004-02-17T00:00:00-05:00
268872,cab64913-c350-44cc-bb65-85b3fa970cc4,YY,"MORRISON & FOERSTER, LLP",25897,VISA INC (FKA VISA U S A INC ),2003,year_end,PHA,,"Education, Dept of,Federal Deposit Insurance Corporation (FDIC),Federal Reserve System,Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Office of the Comptroller of the Currency (OCC),Office of Thrift Supervision (OTS),SENATE,Treasury, Dept of",140000,,0,0,2004-02-17T00:00:00-05:00
268929,07d159af-455f-42c2-a59a-8b389b4ba4df,YY,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,3457,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,2003,year_end,PHA,,"Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,60000,0,0,2004-02-17T00:00:00-05:00
268973,f27d5285-ee72-4bf7-842d-90a4e97e65cc,YY,"ML STRATEGIES, LLC",25603,PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA (PHRMA),2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2004-02-17T00:00:00-05:00
268996,567b9aa5-dcc9-4fe9-b00a-92c04955b048,YY,"WILLIAMS AND JENSEN, PLLC",41454,NOVARTIS INC,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2004-02-17T00:00:00-05:00
269059,af67d16a-1c25-4185-9422-940ccf752853,YY,"THE OB-C GROUP, LLC",29802,BIOTECHNOLOGY INDUSTRY ORGANIZATION,2003,year_end,PHA,,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",160000,,0,0,2004-02-17T00:00:00-05:00
269520,fb024f38-a8af-4c2b-9ac5-8dace6626f18,YY,MCGUINESS & HOLCH,24464,BARR LABS,2003,year_end,PHA,Issues relating to FDA drug approval time; issues relating to the market exclusivity of drugs.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2004-02-18T00:00:00-05:00
269637,a5b3718d-9069-48d7-830e-b8415214eb40,YY,JORDEN BURT LLP,43398,BLUECROSS BLUESHIELD OF FLORIDA,2003,year_end,PHA,,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2004-02-18T00:00:00-05:00
269857,7f875fc4-a341-4b74-8e90-c602ffecc4af,YY,JORDEN BURT LLP,43398,KOS PHARMACEUTICALS,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2004-02-19T00:00:00-05:00
270107,870c1d39-14ea-4487-bd0b-9b2d554fa64d,YY,HANCE SCARBOROUGH,17443,PARRY ROMANI DECONCINI & SYMMS,2003,year_end,PHA,,,20000,,0,0,2004-02-20T00:00:00-05:00
270227,c36d74df-15c6-47d1-ae14-17768bbddcc6,YY,GILBERT'S LLP,67876,APOTEX INC,2003,year_end,PHA,,"Federal Trade Commission (FTC),Food & Drug Administration (FDA)",15000,,0,0,2004-02-20T00:00:00-05:00
270387,914917d2-8ae7-4cc9-b644-9e448a03e6f4,YY,US STRATEGIES,38825,IVAX,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2004-02-24T00:00:00-05:00
270388,b25f606a-8554-4457-afb6-a78a83fa8c99,YY,ASSOCIATION FOR ACCESSIBLE MEDICINES,16032,ASSOCIATION FOR ACCESSIBLE MEDICINES,2003,year_end,PHA,,"Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,300000,0,0,2004-02-24T00:00:00-05:00
270464,085d5607-18ee-4461-9732-1faced5dc897,YY,MEDICAL ASSOCIATION OF GEORGIA,24783,MEDICAL ASSOCIATION OF GEORGIA,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",,20000,0,0,2004-02-24T00:00:00-05:00
270625,bf70c2f3-2744-4022-96bf-82af2785c27c,YY,THE KROGER CO.,88212,KROGER CO,2003,year_end,PHA,,"Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,0,0,0,2004-02-24T00:00:00-05:00
270837,abe35353-7d03-4a6e-b3ef-d2fa14654431,YY,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2003,year_end,PHA,,"Agriculture, Dept of (USDA),Education, Dept of,Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,Social Security Administration (SSA),State, Dept of (DOS)",,80000,0,0,2004-02-24T00:00:00-05:00
271678,6936c652-db05-45fc-aab2-dd64a9d6ee00,YY,HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA),28776,HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA),2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",,80000,0,0,2004-03-02T00:00:00-05:00
271767,04f28c01-5081-440d-8699-523be1f461b7,YY,ANTHEM HEALTH PLANS OF VIRGINIA INC,38472,ANTHEM HEALTH PLANS OF VIRGINIA INC,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2004-03-03T00:00:00-05:00
272060,c5b514b0-7159-4ca9-b06c-332a8e61fcf7,YY,THE POTOMAC GROUP,31918,WALGREENS,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2004-03-03T00:00:00-05:00
272153,70dd2b79-71a9-4d8b-9a9d-4b59c1b49249,YY,POLICY DIRECTIONS INC.,31747,ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ),2003,year_end,PHA,,"Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2004-03-03T00:00:00-05:00
272156,acb71b5c-69fa-46e5-a025-472536f06822,YY,"RYAN MACKINNON VASAPOLI AND BERZOK, LLP",30187,PFIZER INC,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2004-03-03T00:00:00-05:00
272923,339eb6ce-cf60-4e0a-ba19-7818cc7c2917,YY,"BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC.",6382,BLUE CROSS AND BLUE SHIELD OF FLORIDA INC,2003,year_end,PHA,,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,320000,0,0,2004-03-03T00:00:00-05:00
273056,811192ab-7ad7-410e-abb0-b32f6b609656,YY,"WELLMARK, INC.",40910,WELLMARK INC,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",,0,0,0,2004-03-03T00:00:00-05:00
273240,efe80bcc-2d62-43bc-a399-c353e6013b4c,YY,ASSET & EQUITY CORPORATION,4403,THERAGENICS CORPORATION,2003,year_end,PHA,,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2004-03-03T00:00:00-05:00
273312,03defeb1-0e63-4075-8e52-0850f0739175,YY,MEREDITH MCGEHEE,79858,INTERNATIONAL AIDS VACCINE INITIATIVE,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2004-03-04T00:00:00-05:00
273504,dc54adf3-2239-48cb-a8bc-58a2d379fad4,YY,"ROBERT BETZ ASSOCIATES, LLC",6121,HEALTH INDUSTRY GROUP PURCHASING ASSN,2003,year_end,PHA,,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2004-03-05T00:00:00-05:00
273952,7c88a307-6ed4-438d-ab3c-5deb09d856b9,YY,UNIVERSITY OF PITTSBURGH MEDICAL CENTER,32065,UNIVERSITY OF PITTSBURGH MEDICAL CENTER,2003,year_end,PHA,,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Bureau of Investigation (FBI),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,White House Office",,200000,0,0,2004-03-09T00:00:00-05:00
274231,3324a884-8c3e-4a4d-a867-e60e7b4d9733,YY,"PARRY, ROMANI, DECONCINI & SYMMS",30792,CMTE TO ADVANCE COMPOUNDING PHARMACY,2003,year_end,PHA,,"HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2004-03-10T00:00:00-05:00
274318,72008861-ab95-4a48-a27c-739bce5608c4,YY,WYETH,2558,WYETH,2003,year_end,PHA,,"Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Security Council (NSC),SENATE,State, Dept of (DOS),Treasury, Dept of,U.S. Trade Representative (USTR),Vice President of the U.S.",,1500000,0,0,2004-03-11T00:00:00-05:00
274342,0fa36820-499f-43e0-ad91-c1533214cfcf,YY,ANIMAL HEALTH INSTITUTE,4037,ANIMAL HEALTH INSTITUTE,2003,year_end,PHA,,"Agriculture, Dept of (USDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,20000,0,0,2004-03-12T00:00:00-05:00
274348,f45567c7-96f2-4639-91c5-05dc3c503b07,YY,AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY,46803,AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY,2003,year_end,PHA,,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,20000,0,0,2004-03-12T00:00:00-05:00
275136,d80869a9-2332-4dd2-b93f-1b03421e25dd,YY,"ABERNATHY CONSULTANTS, CATHY",69151,PHARMACEUTICAL RESEARCH ASSN (PHRMA),2003,year_end,PHA,,HOUSE OF REPRESENTATIVES,140000,,0,0,2004-03-16T00:00:00-05:00
275268,4fbf218b-3261-45ac-9aa6-4f120affe5e2,YY,WALMART INC.,40305,WALMART INC,2003,year_end,PHA,,"Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,Transportation, Dept of (DOT),U.S. Trade Representative (USTR),White House Office",,540000,0,0,2004-03-17T00:00:00-05:00